📰 Edison Platform News
Edison Platform News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Edison Platform. Real-time updates on events, politics, business and more.
October 9, 2023
The U.S. Food and Drug Administration has approved the use of sound waves to break down tumors—a technique called histotripsy—in humans for liver treatment.
August 30, 2022
/PRNewswire/ -- Today Edison Interactive (EI), the leader in connected device ecosystems, announced its platforms content is now faster with nearly no latency...
August 16, 2022
/PRNewswire/ -- Inc. Magazine today revealed that Edison Interactive (EI) is ranked 1105 on its annual Inc. 5000 list, a prestigious compilation of the...
August 16, 2022
Innovative content-delivery solution among the nations fastest-growing privately held companiesDENVER, Aug. 16, 2022 /PRNewswire/ -- Inc. Magazin...
August 16, 2022
/PRNewswire/ -- Inc. Magazine today revealed that Edison Interactive (EI) is ranked 1105 on its annual Inc. 5000 list, a prestigious compilation of the...
May 31, 2022
Company Continues to Build as It Prepares for FDA Submission and Clearance of Its Breakthrough Therapy MINNEAPOLIS, May 31, 2022 /PRNewswire/ -- HistoSonics, (www.histosonics.com), the
March 18, 2022
With its two major announcements at the Global Health Conference & Exhibition in Orlando, the company signaled it is aiming to help providers access more in-depth, real-time patient data to improve clinical decision-making and care.
December 22, 2021
Investorideas.com , a global investor news source covering Artificial Intelligence issues a sector snapshot on the role of AI in healthcare, featuring technology company GBT Technologies Inc. . Read... | December 22, 2021
December 22, 2021
Point Roberts, Washington and Vancouver, British Columbia--(Newsfile Corp. - December 22, 2021) - Investorideas.com (https://www.investorideas.com/), a global investor news source covering Artificial
December 9, 2021
EIT Health partners, GE Healthcare and Optellum, have joined forces to advance lung cancer diagnosis with artificial intelligence (AI). They recently signed a letter of intent to collaborate to advance precision diagnosis and treatment of lung cancer. GE Healthcare is a global leader in medical imaging solutions. Optellum is the leader in AI decision support for the early diagnosis and optimal treatment of lung cancer. Business leaders from both companies have attended EIT Health start-up compet...